Mark Bower
#154,145
Most Influential Person Now
Researcher
Mark Bower's AcademicInfluence.com Rankings
Mark Bowerengineering Degrees
Engineering
#6359
World Rank
#7680
Historical Rank
Electrical Engineering
#1885
World Rank
#1987
Historical Rank
Mark Bowercomputer-science Degrees
Computer Science
#8337
World Rank
#8764
Historical Rank
Computational Linguistics
#1837
World Rank
#1856
Historical Rank
Machine Learning
#3392
World Rank
#3433
Historical Rank
Artificial Intelligence
#3690
World Rank
#3743
Historical Rank
Download Badge
Engineering Computer Science
Mark Bower's Degrees
- PhD Computer Science Stanford University
- Masters Electrical Engineering University of California, Berkeley
Similar Degrees You Can Earn
Why Is Mark Bower Influential?
(Suggest an Edit or Addition)Mark Bower's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- A trithorax–like gene is interrupted by chromosome 11q23 translocations in acute leukaemias (1992) (507)
- British HIV Association guidelines for the treatment of HIV‐1‐positive adults with antiretroviral therapy 2012 (2012) (387)
- Antibacterial prophylaxis after chemotherapy for solid tumors and lymphomas. (2005) (380)
- Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection. (2009) (343)
- Association of Prior Antibiotic Treatment With Survival and Response to Immune Checkpoint Inhibitor Therapy in Patients With Cancer. (2019) (315)
- Phase I trial of temozolomide using an extended continuous oral schedule. (1998) (279)
- EMA/CO for high-risk gestational trophoblastic tumors: results from a cohort of 272 patients. (1997) (273)
- Immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma. (2005) (269)
- Viable malignant cells after primary chemotherapy for disseminated nonseminomatous germ cell tumors: prognostic factors and role of postsurgery chemotherapy--results from an international study group. (2001) (240)
- Fifty years of multicentric Castleman's disease (2004) (214)
- Multicentre CRC phase II trial of temozolomide in recurrent or progressive high-grade glioma (1997) (210)
- A Meta-analysis of Transient Elastography for the Detection of Hepatic Fibrosis (2010) (203)
- Changes in acquired immunodeficiency syndrome-related lymphoma since the introduction of highly active antiretroviral therapy. (2000) (202)
- HIV-Associated Anal Cancer: Has Highly Active Antiretroviral Therapy Reduced the Incidence or Improved the Outcome? (2004) (197)
- British HIV Association guidelines for the treatment of HIV‐1‐positive adults with antiretroviral therapy 2012 (Updated November 2013. All changed text is cast in yellow highlight.) (2014) (195)
- British HIV Association guidelines for HIV‐associated malignancies 2008 (2008) (191)
- A comparison of regimens based on non-nucleoside reverse transcriptase inhibitors or protease inhibitors in preventing Kaposi's sarcoma (2003) (185)
- Brief Communication: Rituximab in HIV-Associated Multicentric Castleman Disease (2007) (171)
- Renal Dysfunction With Tenofovir Disoproxil Fumarate-Containing Highly Active Antiretroviral Therapy Regimens Is Not Observed More Frequently: A Cohort and Case-Control Study (2004) (167)
- Highly active anti-retroviral therapy (HAART) prolongs time to treatment failure in Kaposi's sarcoma. (1999) (167)
- KSHV-encoded miRNAs target MAF to induce endothelial cell reprogramming. (2010) (164)
- AN OPEN-LABEL STUDY OF TENOFOVIR IN HIV-1 AND HEPATITIS B VIRUS CO-INFECTED INDIVIDUALS (2002) (161)
- HIV-related lung cancer in the era of highly active antiretroviral therapy (2003) (156)
- AIDS-related malignancies: changing epidemiology and the impact of highly active antiretroviral therapy (2006) (152)
- EBNA3B-deficient EBV promotes B cell lymphomagenesis in humanized mice and is found in human tumors. (2012) (152)
- The role of immune suppression and HHV-8 in the increasing incidence of HIV-associated multicentric Castleman's disease. (2009) (151)
- The Charing Cross Hospital experience with temozolomide in patients with gliomas. (1996) (149)
- The value of anal cytology and human papillomavirus typing in the detection of anal intraepithelial neoplasia: a review of cases from an anoscopy clinic (2005) (149)
- Transmission of Hepatitis C Virus Among HIV-Positive Homosexual Men and Response to a 24-Week Course of Pegylated Interferon and Ribavirin (2005) (143)
- Risk of cancers during interrupted antiretroviral therapy in the SMART study (2007) (141)
- British HIV Association guidelines for the treatment of HIV‐1‐positive adults with antiretroviral therapy 2015 (2016) (140)
- Clinical Features and Outcome in HIV-Associated Multicentric Castleman's Disease. (2011) (134)
- VIROLOGICAL SUPPRESSION AT 6 MONTHS IS RELATED TO CHOICE OF INITIAL REGIMEN IN ANTIRETROVIRAL-NAÏVE PATIENTS: A COHORT STUDY (2002) (130)
- Topical calcipotriol treatment in advanced breast cancer (1991) (128)
- HIV status does not influence outcome in patients with classical Hodgkin lymphoma treated with chemotherapy using doxorubicin, bleomycin, vinblastine, and dacarbazine in the highly active antiretroviral therapy era. (2012) (124)
- A Prognostic Index for Systemic AIDS-Related Non-Hodgkin Lymphoma Treated in the Era of Highly Active Antiretroviral Therapy (2005) (121)
- Kaposi sarcoma (2019) (121)
- Human immunodeficiency virus‐associated plasmablastic lymphoma (2012) (119)
- Toll-like receptor 4 mediates innate immunity to Kaposi sarcoma herpesvirus. (2008) (117)
- How I treat HIV-associated multicentric Castleman disease. (2010) (117)
- PD-L1 (2017) (117)
- A double-blind, randomized controlled trial of the use of imiquimod cream for the treatment of anal canal high-grade anal intraepithelial neoplasia in HIV-positive MSM on HAART, with long-term follow-up data including the use of open-label imiquimod (2010) (116)
- Surveillance policy for stage I ovarian germ cell tumors. (1997) (113)
- Protease inhibitors potentiate chemotherapy-induced neutropenia. (2004) (113)
- British HIV Association guidelines for HIV‐associated malignancies 2014 (2014) (110)
- Activity of thalidomide in AIDS-related Kaposi's sarcoma and correlation with HHV8 titre (1998) (110)
- Immune reconstitution inflammatory syndrome associated with Kaposi sarcoma: higher incidence and mortality in Africa than in the UK (2013) (105)
- A prognostic index for AIDS-associated Kaposi's sarcoma in the era of highly active antiretroviral therapy (2006) (104)
- Treatment of men with metastatic non-seminomatous germ cell tumours with cyclical POMB/ACE chemotherapy. (1997) (104)
- Antiretroviral treatment regimens and immune parameters in the prevention of systemic AIDS-related non-Hodgkin's lymphoma. (2004) (101)
- Why does cytotoxic chemotherapy cure only some cancers? (2009) (98)
- The effect of HAART in 254 consecutive patients with AIDS-related Kaposi's sarcoma (2009) (97)
- Treatment of HIV-associated invasive anal cancer with combined chemoradiation. (2000) (97)
- PD-1 expression on natural killer cells and CD8(+) T cells during chronic HIV-1 infection. (2012) (96)
- Surveillance for stage I testicular germ cell tumours: results and cost benefit analysis of management options. (2000) (94)
- Effects of combination chemotherapy and highly active antiretroviral therapy on immune parameters in HIV-1 associated lymphoma (2002) (93)
- Clinical Portrait of the SARS-CoV-2 Epidemic in European Patients with Cancer (2020) (93)
- A comparison of patients with relapsed and chemo-refractory gestational trophoblastic neoplasia (2007) (92)
- Influence of chemotherapy for gestational trophoblastic disease on subsequent pregnancy outcome (1998) (91)
- Eurogin 2016 Roadmap: how HPV knowledge is changing screening practice (2017) (86)
- Phase III Vehicle-Controlled, Multi-Centered Study of Topical Alitretinoin Gel 0.1% in Cutaneous AIDS-Related Kaposi’s Sarcoma (2001) (83)
- Prospective stage-stratified approach to AIDS-related Kaposi's sarcoma. (2014) (82)
- Ritonavir-boosted atazanavir exposure is associated with an increased rate of renal stones compared with efavirenz, ritonavir-boosted lopinavir and ritonavir-boosted darunavir (2011) (78)
- Chemotherapy for gestational trophoblastic tumours hastens menopause by 3 years. (1998) (78)
- Prevalence and clinical correlations of MLL gene rearrangements in AML-M4/5. (1994) (76)
- Non-AIDS defining cancers in the D:A:D Study - time trends and predictors of survival: a cohort study (2013) (74)
- Does HIV adversely influence the outcome in advanced non-small-cell lung cancer in the era of HAART? (2003) (70)
- Antibiotic therapy and outcome from immune-checkpoint inhibitors (2019) (69)
- Medullary thyroid cancer: the role of radiotherapy in local control. (1996) (69)
- FDG-PET/CT imaging in the management of HIV-associated multicentric Castleman’s disease (2009) (68)
- Management of placental site trophoblastic tumors. (1998) (68)
- Loss of chromosome 10 is an independent prognostic factor in high-grade gliomas (1999) (67)
- Hepatocellular carcinoma, human immunodeficiency virus and viral hepatitis in the HAART era. (2008) (64)
- Plasma HHV8 DNA predicts relapse in individuals with HIV-associated multicentric Castleman disease. (2011) (64)
- CD4 counts and the risk of systemic non-Hodgkin’s lymphoma in individuals with HIV in the UK (2009) (63)
- Impact of antiretroviral choice on hypercholesterolaemia events: the role of the nucleoside reverse transcriptase inhibitor backbone (2005) (62)
- Immunotherapy for renal cell cancer. (1998) (61)
- Excellent immunological recovery following CODOX-M/IVAC, an effective intensive chemotherapy for HIV-associated Burkitt's lymphoma (2010) (60)
- Human immunodeficiency virus-associated primary lung cancer in the era of highly active antiretroviral therapy: a multi-institutional collaboration. (2010) (59)
- High-resolution anoscopy screening of HIV-positive MSM: longitudinal results from a pilot study (2014) (59)
- Activity and safety of pegylated liposomal doxorubicin as first-line therapy in the treatment of non-visceral classic Kaposi's sarcoma: a multicenter study. (2008) (59)
- Undetectable ultrasensitive PSA after radical prostatectomy for prostate cancer predicts relapse-free survival (2000) (57)
- Dupuytren's contractures in patients infected with HIV. (1990) (57)
- Target prices for mass production of tyrosine kinase inhibitors for global cancer treatment (2016) (56)
- Presenting Features and Early Mortality from SARS-CoV-2 Infection in Cancer Patients during the Initial Stage of the COVID-19 Pandemic in Europe (2020) (56)
- Paclitaxel for anthracycline-resistant AIDS-related Kaposi's sarcoma: clinical and angiogenic correlations. (2003) (55)
- The heat-shock protein receptor CD91 is up-regulated in monocytes of HIV-1-infected "true" long-term nonprogressors. (2003) (55)
- Chemoradiotherapy for anal cancer in HIV patients causes prolonged CD4 cell count suppression. (2012) (54)
- A systematic review of anal squamous cell carcinoma in inflammatory bowel disease. (2013) (54)
- Programmed death (PD)‐1 molecule and its ligand PD‐L1 distribution among memory CD4 and CD8 T cell subsets in human immunodeficiency virus‐1‐infected individuals (2009) (54)
- Lymph Nodes Involved by Multicentric Castleman Disease Among HIV-positive Individuals are Often Involved by Kaposi Sarcoma (2008) (53)
- Anal intraepithelial neoplasia in HIV positive people (2001) (52)
- HIV status does not impair the outcome of patients diagnosed with diffuse large B-cell lymphoma treated with R-CHOP in the cART era (2014) (52)
- Cytokine changes during rituximab therapy in HIV-associated multicentric Castleman disease. (2009) (52)
- Multicenter study of human immunodeficiency virus-related germ cell tumors. (2003) (51)
- Management of resistant gestational trophoblastic tumors. (1998) (50)
- Highly active antiretroviral therapy and human immunodeficiency virus-associated primary cerebral lymphoma. (2006) (49)
- Structure and expression of the human trithorax-like gene 1 involved in acute leukemias. (1993) (49)
- Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study (2021) (49)
- The significance of the detection of cytomegalovirus in the bronchoalveolar lavage fluid in AIDS patients with pneumonia. (1990) (48)
- AIDS related systemic non-Hodgkin's lymphoma (2000) (48)
- Chromosome 11q23 translocations in both infant and adult acute leukemias are detected by in situ hybridization with a yeast artificial chromosome. (1992) (48)
- A trial of caspofungin salvage treatment in PCP pneumonia (2010) (47)
- A double-blind study of the efficacy of metronidazole gel in the treatment of malodorous fungating tumours. (1992) (47)
- Absence of cyclin‐D2 and Bcl‐2 expression within the germinal centre type of diffuse large B‐cell lymphoma identifies a very good prognostic subgroup of patients (2007) (44)
- Acquired immunodeficiency syndrome-related lymphoma in the era of highly active antiretroviral therapy. (2003) (44)
- Disease-associated dendritic cells respond to disease-specific antigens through the common heat shock protein receptor. (2003) (43)
- Pulmonary Kaposi sarcoma in the era of highly active antiretroviral therapy (2006) (43)
- Prognostic models to predict survival in patients with advanced non-small cell lung cancer treated with first-line chemo- or targeted therapy (2016) (43)
- Placental site trophoblastic tumor: molecular analysis and clinical experience. (1996) (42)
- Hepatitis C virus infection in HIV type 1-infected individuals does not accelerate a decrease in the CD4+ cell count but does increase the likelihood of AIDS-defining events. (2005) (41)
- Prognostic factors in patients with HIV‐associated peripheral T‐cell lymphoma: A multicenter study (2011) (41)
- Should cervical cancer be an acquired immunodeficiency syndrome-defining cancer? (2006) (40)
- The frequency and reasons for antiretroviral switching with specific antiretroviral associations: the SWITCH study. (2010) (40)
- Lack of response of anal intra-epithelial neoplasia to highly active antiretroviral therapy. (2003) (40)
- The Role of Transbronchial Fine Needle Aspiration in an Integrated Care Pathway for the Assessment of Patients with Suspected Lung Cancer (2006) (40)
- The risks and incidence of K65R and L74V mutations and subsequent virologic responses. (2008) (39)
- The value of serum cryptococcal antigen in the diagnosis of cryptococcal infection in patients infected with the human immunodeficiency virus. (1990) (39)
- Relapse of HHV8-positive multicentric Castleman disease following rituximab-based therapy in HIV-positive patients. (2017) (39)
- Time-Dependent COVID-19 Mortality in Patients With Cancer: An Updated Analysis of the OnCovid Registry. (2021) (39)
- Hyponatremia normalization as an independent prognostic factor in patients with advanced non-small cell lung cancer treated with first-line therapy (2016) (38)
- The evidence-based treatment of AIDS-related non-Hodgkin's lymphoma. (2004) (38)
- Absence of association between individual thymidine analogues or nonnucleoside analogues and lipid abnormalities in HIV-1-infected persons on initial therapy. (2000) (37)
- Facing up to the ongoing challenge of Kaposi's sarcoma (2015) (37)
- Immunologic recovery in survivors following chemotherapy for AIDS-related non-Hodgkin lymphoma. (2008) (37)
- Leptomeningeal disease in AIDS-related non-Hodgkin's lymphoma (2003) (36)
- Rituximab as retreatment for rituximab pretreated HIV-associated multicentric Castleman disease. (2007) (36)
- Randomized trial to compare the efficacy and toxicity of cyclophosphamide, methotrexate and 5-fluorouracil (CMF) with methotrexate mitoxantrone (MM) in advanced carcinoma of the breast (1999) (35)
- HIV-related lung cancer - a growing concern? (2003) (35)
- Conservation of unique cell-surface CD antigen mosaics in HIV-1-infected individuals. (2005) (35)
- Prospective cohort study showing changes in the monthly incidence of Pneumocystis carinii pneumonia (2003) (35)
- Association of Coloproctology of Great Britain & Ireland (ACPGBI): Guidelines for the Management of Cancer of the Colon, Rectum and Anus (2017) – Anal Cancer (2017) (34)
- Resolution of AIDS-related Castleman's Disease with Anti-CD20 Monoclonal Antibodies is Associated with Declining IL-6 and TNF-α Levels (2004) (34)
- Epigenetics: an emerging technology in the diagnosis and treatment of cancer. (2006) (34)
- Influence of HIV Infection on the Natural History of Hepatocellular Carcinoma: Results From a Global Multicohort Study. (2019) (34)
- Imaging features of multicentric Castleman's disease in HIV infection. (2004) (34)
- AIDS-related non-Hodgkin's lymphoma in the first decade of highly active antiretroviral therapy. (2006) (34)
- Adherence to trizivir and tenofovir as a simplified salvage regimen is associated with suppression of viraemia and a decreased cholesterol. (2005) (34)
- HIV-associated bladder cancer: a case series evaluating difficulties in diagnosis and management (2009) (33)
- Prognostic factors for advanced‐stage human immunodeficiency virus‐associated classical Hodgkin lymphoma treated with doxorubicin, bleomycin, vinblastine, and dacarbazine plus combined antiretroviral therapy: A multi‐institutional retrospective study (2015) (33)
- The CD8 and CD4 T-Cell Response against Kaposi's Sarcoma-Associated Herpesvirus Is Skewed Towards Early and Late Lytic Antigens (2009) (33)
- The role of tumour markers in the diagnosis and treatment of testicular germ cell cancers. (1997) (32)
- Treatment outcome in presumed and confirmed AIDS-related primary cerebral lymphoma. (1999) (32)
- Insights into the molecular biology and sero-epidemiology of Kaposi's sarcoma (2003) (31)
- The successful treatment of haemophagocytic syndrome in patients with human immunodeficiency virus‐associated multi‐centric Castleman's disease (2008) (30)
- Recent insights into the pathogenesis of Kaposi's sarcoma. (1996) (30)
- Thyroid dysfunction and relationship to antiretroviral therapy in HIV-positive individuals in the HAART era. (2009) (30)
- Hepatocellular carcinoma: an evolving challenge in viral hepatitis and HIV coinfection (2017) (29)
- HIV‐associated multicentric Castleman's disease (2008) (29)
- HIV-associated Hodgkin's disease (2000) (28)
- The efficacy of ritonavir in the prevention of AIDS‐related Kaposi's sarcoma (2004) (28)
- Hepatitis C infection is not associated with systemic HIV‐associated non‐hodgkin's lymphoma: A cohort study (2005) (28)
- NKG2C+ NK Cells Are Enriched in AIDS Patients with Advanced-Stage Kaposi's Sarcoma (2006) (28)
- Adding rituximab to CODOX-M/IVAC chemotherapy in the treatment of HIV-associated Burkitt lymphoma is safe when used with concurrent combination antiretroviral therapy (2015) (28)
- Highly active anti‐retroviral therapy (HAART)‐induced maintenance of adaptive but not innate immune parameters is associated with protection from HIV‐induced mortality (2006) (28)
- A randomized study comparing a three- and four-drug HAART regimen in first-line therapy (QUAD study). (2005) (28)
- Acquired immunodeficiency syndrome‐related systemic non‐Hodgkin's lymphoma (2001) (28)
- Determinants of enhanced vulnerability to coronavirus disease 2019 in UK patients with cancer: a European study (2021) (28)
- The immunological effects of concomitant highly active antiretroviral therapy and liposomal anthracycline treatment of HIV-1-associated Kaposi's sarcoma. (2002) (27)
- Cidofovir for the treatment of Kaposi’s sarcoma in an HIV‐negative homosexual man (1999) (27)
- Chemotherapy for ovarian germ cell tumours. (1996) (27)
- Outcome of patients with HIV-related germ cell tumours: a case–control study (2004) (26)
- Nadir B cell counts are significantly correlated with the risk of Kaposi's sarcoma (2004) (26)
- Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study (2022) (26)
- Pre-treatment systemic immune-inflammation represents a prognostic factor in patients with advanced non-small cell lung cancer. (2019) (26)
- What can oncologists learn from HIV? (2003) (25)
- Endothelial cell transfection with cationic liposomes and herpes simplex-thymidine kinase mediated killing (1998) (25)
- Impact of highly effective antiretroviral therapy on the risk for Hodgkin lymphoma among people with human immunodeficiency virus infection (2012) (25)
- The significance of the time interval between antecedent pregnancy and diagnosis of high-risk gestational trophoblastic tumours (2006) (25)
- The management of high‐risk gestational trophoblastic tumours (GTT) (1998) (25)
- Head and neck cancer in patients with human immunodeficiency virus-1 infection: incidence, outcome and association with Epstein-Barr virus (2004) (25)
- Primary esophageal carcinoma in the era of highly active antiretroviral therapy. (2010) (24)
- Cardiotoxicity after liposomal anthracyclines. (2004) (24)
- Recent advances in HIV-associated Kaposi sarcoma (2019) (24)
- Human trithorax gene rearrangements in therapy-related acute leukaemia after etoposide treatment. (1994) (23)
- Stem cell mobilization in HIV seropositive patients with lymphoma (2013) (23)
- Cessation of Cigarette Smoking and the Impact on Cancer Incidence in Human Immunodeficiency Virus–infected Persons: The Data Collection on Adverse Events of Anti-HIV Drugs Study (2018) (23)
- Immune Reconstitution Inflammatory Syndrome Mimicking Relapse of AIDS Related Lymphoma in Patients with HIV 1 Infection (2003) (23)
- DUSP16 is an epigenetically regulated determinant of JNK signalling in Burkitt's lymphoma (2010) (23)
- A randomized trial to investigate the recycling of stavudine and didanosine with and without hydroxyurea in salvage therapy (RESTART). (2004) (22)
- Phase II trial of 13- cis -retinoic acid for poor risk HIV-associated Kaposi's sarcoma (1997) (22)
- The Effect of Statins on HIV Rebound and Blips (2005) (22)
- AIDS-associated Kaposi's sarcoma associated with a low viral load and a high CD4 cell count. (2008) (22)
- Paclitaxel for AIDS-associated Kaposi’s sarcoma (2005) (22)
- Randomized cross-over comparison of liposomal daunorubicin versus observation for early Kaposi's sarcoma (1996) (22)
- Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: the OnCovid Inflammatory Score (2021) (21)
- Diagnostic criteria schemes for multicentric Castleman disease in 75 cases. (2014) (21)
- Killing of Kaposi's sarcoma-associated herpesvirus-infected fibroblasts during latent infection by activated natural killer cells (2011) (21)
- Castleman disease (2019) (21)
- Weekly alternating combination chemotherapy for good prognosis AIDS-related lymphoma. (2000) (21)
- Fibrolamellar hepatocellular carcinoma responsive to platinum-based combination chemotherapy. (1996) (21)
- Chemotherapy for advanced cholangiocarcinoma: what is standard treatment? (2006) (21)
- Assessment of the efficacy of total lymphocyte counts as predictors of AIDS defining infections in HIV-1 infected people (2005) (21)
- CD20 expression in the HHV‐8‐infected lymphoid cells in multicentric Castleman disease (2009) (21)
- PROX1 is a transcriptional regulator of MMP14 (2018) (20)
- Phase I study of TNFα AutoVaccIne in Patients with metastatic cancer (2005) (20)
- The common heat shock protein receptor CD91 is up‐regulated on monocytes of advanced melanoma slow progressors (2004) (20)
- Elevated plasma lipopolysaccharide is not sufficient to drive natural killer cell activation in HIV-1-infected individuals (2009) (20)
- The clinical application of plasma Kaposi sarcoma herpesvirus viral load as a tumour biomarker: results from 704 patients (2016) (20)
- A comparison of the CD4 response to antiretroviral regimens in patients commencing therapy with low CD4 counts. (2004) (20)
- Presence of monoclonal T-cell populations in B-cell post-transplant lymphoproliferative disorders (2011) (20)
- The significance of Epstein–Barr virus detected in the cerebrospinal fluid of people with HIV infection (2007) (19)
- Non-AIDS-defining cancers (2009) (19)
- The exclusion of people living with HIV (PLWH) from clinical trials in lymphoma (2015) (19)
- HIV-associated Burkitt lymphoma: outcomes from a US-UK collaborative analysis. (2021) (18)
- Kaposi sarcoma-associated immune reconstitution inflammatory syndrome: in need of a specific case definition. (2012) (18)
- Life-threatening complication of sputum induction (1990) (18)
- Salvage Surgery for Residual Primary and Locally Recurrent Anal Squamous Cell Carcinoma After Chemoradiotherapy in HIV-positive Individuals (2014) (18)
- Non-Hodgkin’s lymphoma and the CNS: prophylaxis and therapy in immunocompetent and HIV-positive individuals (2006) (18)
- Short communication: NKG2C+ NK cells contribute to increases in CD16+CD56- cells in HIV type 1+ individuals with high plasma viral load. (2013) (18)
- The prognostic and predictive role of hyponatremia in patients with advanced non-small cell lung cancer (NSCLC) with bone metastases (2018) (18)
- In situ hybridisation analysis of a homogeneously staining region at 11q23–24 in an acute myeloid leukaemia (M5) using yeast artificial chromosomes (1993) (17)
- The management of lymphoma in the immunosuppressed patient. (2002) (17)
- The albumin‐bilirubin grade uncovers the prognostic relationship between hepatic reserve and immune dysfunction in HIV‐associated hepatocellular carcinoma (2018) (17)
- The changing role of radiotherapy in AIDS-related malignancies. (2003) (17)
- Colorectal cancer in HIV positive individuals: the immunological effects of treatment. (2011) (17)
- Altered phenotype of regulatory T cells associated with lack of human immunodeficiency virus (HIV)‐1‐specific suppressive function (2011) (17)
- The evolution of coreceptor tropism in HIV-infected patients interrupting suppressive antiretroviral therapy. (2011) (17)
- Azathioprine can be safely used in HIV-infected individuals. (2014) (16)
- Potential antiretroviral drug interactions with cyclophosphamide, Doxorubicin, and Etoposide. (2005) (16)
- The presentation and survival of patients with non-cutaneous AIDS-associated Kaposi's sarcoma. (2006) (16)
- Pneumonia due to antibiotic resistant Streptococcus pneumoniae and Pseudomonas aeruginosa in the HAART era. (2003) (15)
- Antibody-targeted MHC complex-directed expansion of HIV-1- and KSHV-specific CD8+ lymphocytes: a new approach to therapeutic vaccination. (2004) (15)
- Interim fluoro-2-deoxy-D-glucose–PET predicts response and progression-free survival in patients with Hodgkin lymphoma and HIV infection (2012) (15)
- Burkitt Lymphoma International Prognostic Index. (2021) (15)
- The collagen prolyl hydroxylases are novel transcriptionally silenced genes in lymphoma (2012) (15)
- Surgical excision alone for stage T1 anal verge cancers in people living with HIV. (2016) (15)
- Natural killer cells are not infected by Kaposi's sarcoma-associated herpesvirus in vivo, and natural killer cell counts do not correlate with the risk of developing Kaposi's sarcoma (2003) (14)
- The Nucleoside Backbone Affects Durability of Efavirenz- or Nevirapine-Based Highly Active Antiretroviral Therapy in Antiretroviral-Naive Individuals (2009) (14)
- The Effect of Sunitinib on Immune Subsets in Metastatic Clear Cell Renal Cancer (2010) (14)
- Programmed death ligand 1 (PD-L1) expression influences the immune-tolerogenic microenvironment in antiretroviral therapy-refractory Kaposi's sarcoma: A pilot study (2017) (14)
- Follicular dendritic cells in multicentric Castleman disease present human herpes virus type 8 (HHV8)‐latent nuclear antigen 1 (LANA1) in a proportion of cases and is associated with an enhanced T‐cell response (2010) (14)
- Antibiotic treatment prior to immune checkpoint inhibitor therapy as a tumor-agnostic predictive correlate of response in routine clinical practice. (2019) (14)
- The durability of virological success of tenofovir and didanosine dosed at either 400 or 250 mg once daily (2005) (14)
- The management of meningeal lymphoma in patients with HIV in the era of HAART: intrathecal depot cytarabine is effective and safe. (2006) (13)
- HIV-related lymphoma (2010) (13)
- HIV-associated anal cancer (2010) (13)
- Blood Epstein–Barr virus DNA does not predict outcome in advanced HIV-associated Hodgkin lymphoma (2018) (13)
- Human immunodeficiency virus--associated renal cell carcinoma: a transatlantic case series. (2008) (13)
- Gastroenteropancreatic Neuroendocrine Tumors in Patients With HIV Infection: A Trans-Atlantic Series (2009) (13)
- Smoke and mirrors: HIV-related lung cancer (2008) (13)
- HIV and the risk of lung cancer. (2004) (13)
- The extent of B‐cell activation and dysfunction preceding lymphoma development in HIV‐positive people (2018) (13)
- Incidence of cancer in individuals receiving chronic zopiclone or eszopiclone requires prospective study. (2005) (13)
- Human chorionic gonadotropin for AIDS-related Kaposi's sarcoma (1995) (13)
- Chemoradiotherapy for anal cancer in HIV patients causes prolonged CD4 cell count suppression. (2012) (13)
- Current perspectives in gliomas (1997) (12)
- Epstein–Barr virus (EBV) genotypes among human immunodeficiency virus (HIV)‐related B‐cell Lymphomas and B‐cell post‐transplant lymphoproliferative disorders (B‐PTLD) – late‐onset lymphomas, especially in the HIV setting, are associated with type‐B‐EBV (2010) (12)
- A case of metastatic transitional cell carcinoma in the testis histologically mimicking intratubular germ cell neoplasia. (1996) (12)
- A PHASE II STUDY OF THALIDOMIDE FOR KAPOSI'S SARCOMA: ACTIVITY AND CORRELATION WITHKSHV DNA LOAD (1997) (12)
- Studies on the allostimulatory function of dendritic cells from HCV-HIV-1 co-infected patients (2004) (12)
- Bone marrow manifestations in multicentric Castleman disease (2016) (12)
- HAART PROLONGS TIME TO TREATMENT FAILURE (TTF) IN KAPOSI'S SARCOMA (KS). (1999) (12)
- No evidence for a polyomavirus association or aetiology in AIDS-associated nonsmall cell lung cancer (2010) (12)
- Hepatitis B reactivation during combination chemotherapy for AIDS-related lymphoma is uncommon and does not adversely affect outcome. (2004) (12)
- Evolution of HIV-Associated Lymphoma Over 3 Decades (2016) (12)
- Comparative pharmacogenomics of antiretroviral and cytotoxic treatments. (2006) (12)
- HIV-associated Kaposi sarcoma and gender. (2007) (12)
- Cryptogenic pseudocirrhosis: a new clinical syndrome of noncirrhotic portal hypertension (unassociated with advanced fibrosis) that can be detected by transient elastography in patients with HIV. (2009) (11)
- Discovery and validation of a novel subgroup and therapeutic target in idiopathic multicentric Castleman disease. (2021) (11)
- Primary cervical lymphoma: a rare presentation to a genitourinary medicine clinic (2013) (11)
- Improving Pharmacists’ Targeting of Patients for Medication Review and Deprescription (2018) (11)
- HIV-related testicular cancer. (2003) (11)
- Molecular cloning and analysis of chromosome band 11q23 involved in leukaemia‐associated translocations (1992) (11)
- A weekly alternating chemotherapy regimen with low toxicity for the treatment of aggressive lymphoma (1996) (11)
- Use of antidepressants and risk of cancer in individuals infected with HIV. (2008) (10)
- Emtricitabine intolerance in treatment-experienced patients switched from lamivudine: a method of assessing toxicity. (2006) (10)
- Systemic Inflammatory Response Is a Prognostic Marker in HIV-Infected Patients with Hepatocellular Carcinoma (2017) (10)
- Kaposi sarcoma in HIV‐negative men who have sex with men (2014) (10)
- COVID-19 Sequelae and the Host Proinflammatory Response: An Analysis From the OnCovid Registry (2022) (10)
- POMB/ACE chemotherapy for mediastinal germ cell tumours. (1997) (10)
- Functional immune characterization of HIV-associated non-small-cell lung cancer. (2018) (10)
- Phase I study of TNFalpha AutoVaccIne in patients with metastatic cancer. (2005) (9)
- The role of the microenvironment in human immunodeficiency virus‐associated classical Hodgkin lymphoma (2014) (9)
- Gene and pathway level analyses of germline DNA-repair gene variants and prostate cancer susceptibility using the iCOGS-genotyping array (2016) (9)
- Do we still need chemotherapy for AIDS-associated Kaposi’s sarcoma? (2013) (9)
- Special Issue: British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012 (2013 update) (2014) (9)
- Oncogenic herpesvirus KSHV triggers hallmarks of alternative lengthening of telomeres (2021) (9)
- Oncogenic Herpesvirus Engages Endothelial Transcription Factors SOX18 and PROX1 to Increase Viral Genome Copies and Virus Production (2020) (9)
- Vaccination against SARS-CoV-2 protects from morbidity, mortality and sequelae from COVID19 in patients with cancer (2022) (9)
- Phase II trial of topotecan (T) as a continuous intravenous infusion in patients (PTS) with high grade gliomas (1997) (9)
- Imaging in multicentric Castleman's disease. (2008) (9)
- Liposomal anthracycline chemotherapy and the risk of second malignancies in patients with Kaposi’s sarcoma (KS) (2014) (8)
- Lecture Notes: Oncology (2006) (8)
- A long-term durable remission with high-dose therapy and autologous stem cell transplant for stage IVB HIV-associated Hodgkins disease (2008) (8)
- An evaluation of patient satisfaction with care provided by a multidisciplinary cancer team (1992) (8)
- Exploiting interleukin 6 in multicentric Castleman's disease. (2014) (8)
- High-dose therapy including carboplatin adjusted for renal function in patients with relapsed or refractory germ cell tumour: outcome and prognostic factors. (1998) (8)
- Prognostic significance of immune subset measurement in individuals with AIDS-associated Kaposi's sarcoma. (2007) (8)
- Kaposi's sarcoma as a model for cancer immunotherapy. (2004) (8)
- Virological failure and subsequent resistance profiles in individuals exposed to atazanavir (2007) (8)
- Ex-vivo recognition of late-lytic CD8 epitopes specific for Kaposi's sarcoma-associated herpesvirus (KSHV) by HIV/KSHV-coinfected individuals. (2011) (8)
- Mitozantrone and methotrexate chemotherapy with and without mitomycin C in the treatment of advanced breast cancer: a randomised clinical trial. (1992) (8)
- A single centre cohort experience with a new once daily antiretroviral drug (2006) (8)
- Burkitt's lymphoma and previous AIDS-defining illnesses are not prognostic factors in AIDS-related non-Hodgkin's lymphoma. (2005) (7)
- Use of ezetimibe during HIV infection. (2008) (7)
- The Host Control of Lytic and Latent Infection with Human Herpesvirus–8 (2006) (7)
- The significance of the time interval between antecedent pregnancy and diagnosis of high-risk gestational trophoblastic tumours (2006) (7)
- Is nelfinavir exposure associated with cancer incidence in HIV-positive individuals? (2016) (6)
- Cell-free DNA as a biomarker in the context of cancer, viruses, and methylation. (2012) (6)
- Nonmelanoma skin cancers among HIV-infected persons in the HAART era. (2012) (6)
- Persistence of long-term COVID-19 sequelae in patients with cancer: An analysis from the OnCovid registry (2022) (6)
- Oncogenic herpesvirus engages the endothelial transcription factors SOX18 and PROX1 to increase viral genome copies and virus production (2019) (6)
- Multiple human papillomavirus types appear to be a feature of anal not cervical intra-epithelial neoplasia. (2003) (6)
- Triple-class antiretroviral agent resistance in a large cohort: prevalence and clinical outcomes. (2008) (6)
- The use of nasal calcitonin spray in the treatment of hypercalcaemia of malignancy (2004) (6)
- Malignancy and all-cause mortality; incidence in adolescents and young adults living with perinatally acquired HIV (2020) (6)
- AIDS-associated malignancies. (2006) (6)
- The relationship between prolonged antiretroviral therapy and cryptogenic liver disease. (2009) (6)
- Etravirine use in clinical practice: 48-week data from a single centre cohort (2008) (6)
- Management of HIV-related lymphoma in HIV treatment centres in North Thames Region (2004) (5)
- PD-L1 expressing granulomatous reaction as an on-target mechanism of steroid-refractory immune hepatotoxicity. (2019) (5)
- Current issues in the biology of AIDS‐related lymphoma (2001) (5)
- Serum-free light chains in HIV-associated lymphoma: no correlation with histology or prognosis (2015) (5)
- Severe vitamin D deficiency in a patient treated for hepatitis B with tenofovir (2012) (5)
- The use of monoclonal antibodies to treat Castleman's disease. (2014) (5)
- Epstein-Barr virus in Burkitt's lymphoma: the missing link. (2009) (5)
- The biology of HIV-associated lymphomas. (1992) (5)
- The effects of HAART on AIDS-related Kaposi's sarcoma and non-Hodgkin's lymphoma. (2006) (5)
- Cancer vaccines: Clinical development challenges and proposed regulatory approaches for patient access to promising treatments (2008) (5)
- Outcomes of autologous stem cell transplantation (ASCT) in patients with relapsed/refractory HIV-associated lymphoma (2016) (5)
- The pharmacokinetics of high-dose methotrexate in people living with HIV on antiretroviral therapy (2015) (5)
- What Is the best treatment for HIV-associated multicentric Castleman disease? (2012) (5)
- Predictive Value of Prostate Specific Antigen in a European HIV-positive Cohort: Does One Size Fit All? (2016) (5)
- Expression of human herpesvirus 8 (HHV‐8), latent nuclear antigen 1 (LANA1) in angiosarcoma in acquired immunodeficiency syndrome (AIDS) – a report of two cases (2007) (5)
- African ancestry and innate immunity contribute to the incidence of multicentric Castleman’s disease in HIV-1/Kaposi’s sarcoma herpesvirus-coinfected individuals (2012) (5)
- The anti‐tumor effects of human immunodeficiency virus protease inhibitors: Ready for real time? (2011) (5)
- 319O The systemic pro-inflammatory response identifies cancer patients with adverse outcomes from SARS-CoV-2 infection (2020) (4)
- Oncological challenges for an ageing population living with HIV. (2017) (4)
- Will local ablation of high grade anal intraepithelial neoplasia prevent invasive anal cancer? (2013) (4)
- HIV-related Kaposi's Sarcoma with Musculoskeletal Involvement in the Modern Antiretroviral Era. (2016) (4)
- Model-Based Inference of Recombination Hotspots in a Highly, Variable Oncogene (2004) (4)
- AIDS-related malignant disease (2013) (4)
- The role of CD91 and heat shock proteins in psoriasis (2005) (4)
- Lessons for HIV from Tuskegee. (2004) (4)
- Improving outcomes for the treatment of Anal Squamous Cell Carcinoma and Anal Intraepithelial Neoplasia (2019) (4)
- Outcome in AIDS-Related Systemic Non-Hodgkin Lymphoma and Leptomeningeal Disease Is Not Predicted by a CT Brain Scan (2007) (4)
- Comparing the efficacy of Truvada® and Kivexa® combination therapy in HAART-naive individuals with different viral loads (2008) (4)
- Host pharmacogenetics in the treatment of HIV and cancer. (2006) (4)
- The rationale and development of new drugs to treat HIV infection. (2005) (4)
- Anal squamous cell carcinoma in a high HIV prevalence population (2021) (4)
- Model-Based Inference of Recombination Hotspots in a Highly Variable Oncogene (2004) (3)
- The features and outcome of HIV-associated anal cancer in screened and unscreened populations. (2012) (3)
- Tumour infiltrating plasmacytoid dendritic cells in B cell post‐transplant lymphoproliferative disorders, human immunodeficiency virus‐associated B cell lymphomas and immune competent diffuse large B cell lymphomas (2011) (3)
- COVID-19 in breast cancer patients: a subanalysis of the OnCovid registry (2021) (3)
- Significance of Variation Within HIV, EBV, and KSHV Subtypes (2006) (3)
- Non-AIDS defining malignancies (NADM) and immunosuppression: The D:A:D study (2012) (3)
- Non-AIDS-defining cancers in people with HIV infection: a sleeping giant? (2006) (3)
- The isolation of a yeast artificial chromosome which spans the chromosome 11q23 region involved in a number of translocations in acute leukaemias. (1993) (3)
- Pandemic Phase-Adjusted Analysis of COVID-19 Outcomes Reveals Reduced Intrinsic Vulnerability and Substantial Vaccine Protection From Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Breast Cancer. (2023) (3)
- KSHV/HHV8-Associated Lymphoproliferative Disorders: Lessons Learnt from People Living with HIV (2021) (3)
- The molecular genetics of human herpesvirus 8. (2000) (3)
- Cessation of cigarette smoking and the impact on cancer incidence in HIV-positive persons : The D : A : D Study (2018) (3)
- British urological surgery practice: 2. Renal, bladder and testis cancer. (1998) (3)
- Erratum: A trithorax–like gene is interrupted by chromosome 11q23 translocations in acute leukaemias (1993) (2)
- A retrospective, multi-center analysis of treatment intensification for human immunodeficiency virus-positive patients with high-risk diffuse large B-cell lymphoma (2013) (2)
- Prognostication, Survival and Treatment-Related Outcomes in HIV-Associated Burkitt Lymphoma (HIV-BL): A US and UK Collaborative Analysis (2020) (2)
- 1560O Prevalence and impact of COVID-19 sequelae on treatment pathways and survival of cancer patients who recovered from SARS-CoV-2 infection (2021) (2)
- HIV-associated gastric natural killer/T-cell lymphoma (2012) (2)
- A single-center cohort experience of raltegravir in salvage patients failing therapy. (2010) (2)
- Cytotoxic chemotherapy and the evolution of cellular and viral resistance to antiretroviral therapy in HIV- infected individuals with lymphoma (2016) (2)
- Listeria monocytogenes meningitis in an HIV-infected patient. (1989) (2)
- Vitamin D deficiency in the in-patient HIV population: cause or affect? (2008) (2)
- HIV Status does not Impact on Outcome in Patients with Hodgkin Lymphoma Treated with ABVD Chemotherapy in the HAART Era (2011) (2)
- International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK (2016) (2)
- Lymphoid and histiocytic proliferations in HIV-positive patients: problems in diagnosis. (2009) (2)
- Immunotherapy for HIV-associated non-Hodgkin's lymphoma (2009) (2)
- Rituximab therapy for HIV-associated multicentric Castleman disease (2010) (2)
- HIV-associated renal cell cancer. (2007) (2)
- CHANGES IN AIDS‐RELATED LYMPHOMA SINCE THE INTRODUCTION OF HAART: ABSTRACT 47 (2000) (2)
- The current role of surgery in the management of residual disease. (1999) (2)
- A tale of three Hs: HPV, HIV & HAART. (2006) (2)
- Adding rituximab to CODOX-M/IVAC chemotherapy in the treatment of HIV-associated Burkitt Lymphoma is safe when used with concurrent cART (2015) (2)
- HIV-Associated Plasmablastic Lymphoma: A Multi-Institutional Study (2011) (1)
- Paraneoplastic pemphigus in patient infected with the human immunodeficiency virus (2014) (1)
- Lymphoma in the immunocompromised. (2010) (1)
- Rituximab induces long-term remissions in patients with HIV-associated multicentric Castleman's disease (2007) (1)
- Specialist palliative and end-of-life care for patients with cancer and SARS-CoV-2 infection: a European perspective (2021) (1)
- Opposing roles of dendritic cell subsets in HIV-1 infection (2006) (1)
- 10.10 Endocrine and metabolic complications of advanced cancer (2009) (1)
- Serum Proteomics Reveals Distinct Subtypes Associated with Treatment Response in Idiopathic Multicentric Castleman Disease (2018) (1)
- Antibiotic Treatment and Immune Checkpoint Inhibitor Therapy in Patients With Cancer-Reply. (2020) (1)
- Simplified one-step antibody-HLA directed expansion of HIV-specific cytotoxic T lymphocytes: a system suited for use in vivo. (2004) (1)
- EMA/CO for High-Risk Gestational Trophoblastic Tumors (2016) (1)
- What’s the (end) point of cancer vaccines? (2006) (1)
- Comprar Copernicus, Darwin and Freud: Revolutions in the History and Philosophy of Science | Mark Bower | 9781405181839 | Wiley (2009) (1)
- Combination antiretroviral therapy toxicities: a comparison between patients and health care professionals. (2011) (1)
- Natural immunity to SARS-CoV-2 and breakthrough infections in vaccinated and unvaccinated patients with cancer (2022) (1)
- Isolated conjunctival lymphoma metastasis from previous low grade non-Hodgkin’s lymphoma (2005) (1)
- 1169 Placental site trophoblastic tumours at charing cross 1975–1995 (1995) (1)
- Hepatitis B reactivation during combination chemotherapy for AIDS-related lymphoma is uncommon and does not adversely affect outcome. (2004) (1)
- A comparison of the CD 4 response to antiretroviral regimens in patients commencing therapy with low CD 4 counts (2004) (1)
- P17 Response of individuals with high viral load to non‐nucleoside reverse transcriptase inhibitors (2000) (1)
- The unholy trinity of human herpesvirus 8-associated malignancy in a person living with HIV-1. (2018) (1)
- Survival Outcomes for Plasmablastic Lymphoma: An International, Multicentre Study By the Australasian Lymphoma Alliance (2020) (1)
- Faculty Opinions recommendation of HAART and progression to high-grade anal intraepithelial neoplasia in men who have sex with men and are infected with HIV. (2011) (1)
- The influence of HIV status on programmed-death ligands expression in non-small cell lung cancer (2018) (1)
- 1679P Determinants of mortality from SARS-CoV-2 infection in European cancer patients (2020) (1)
- HIV-associated primary lung cancer (LC) in the era of highly active antiretroviral therapy (HAART): a multi-institutional collaboration (2010) (1)
- Burkitt's lymphoma and previous AIDS-defining illnesses are not prognostic factors in AIDS-related non-Hodgkin's lymphoma. Authors' reply (2005) (1)
- A new prognostic index for systemic AIDS-related lymphoma (2005) (1)
- Risk factors for pancreatitis. (1997) (1)
- Targeted treatment of HHV-8-associated multicentric Castleman's disease (2013) (1)
- An HIV-associated mediastinal germ cell tumour complicated by acute myeloid leukaemia. (2007) (1)
- CD8 count measurement has independent prognostic significance in individuals with AIDS-Kaposi sarcoma (2007) (1)
- Determinants of enhanced vulnerability to Covid-19 in U.K. cancer patients: Results from the OnCovid study. (2021) (1)
- The management of high-risk gestational trophoblastic tumours (GTT). (1998) (1)
- Translational review of AIDS-related Kaposi's sarcoma (2007) (1)
- P31 Changes in CD4 count and viral load during chemotherapy for AIDS‐related lymphomas (2000) (1)
- Predictive value of prostate-specific antigen for prostate cancer: a nested case-control study in EuroSIDA (2014) (1)
- PRIMARY RETROPERITONEAL GERM CELL TUMOURS: TREATMENT WITH PLATINUM BASED CHEMOTHERAPY AND EXCISION OF RESIDUAL MASSES (1999) (1)
- Gestational choriocarcinoma. (1995) (1)
- Applicability of Routine Targeted Next-generation Sequencing to Estimate Tumor Mutational Burden (TMB) in Patients Treated With Immune Checkpoint Inhibitor Therapy (2019) (1)
- G-CSF is of little benefit as secondary prophylaxis with liposomal anthracycline in HIV-associated Kaposi's sarcoma (1999) (0)
- LYMPHOID NEOPLASIA Relapse of HHV8-positive multicentric Castleman disease following rituximab-based therapy in HIV-positive patients (2017) (0)
- Primary Central Nervous System Lymphoma (2016) (0)
- Faculty Opinions recommendation of Kaposi's Sarcoma-Associated Herpesvirus Increases PD-L1 and Proinflammatory Cytokine Expression in Human Monocytes. (2019) (0)
- Abstract S01-03: The acute phase response identifies cancer patients with adverse outcomes from SARS-CoV-2 infection as quantified by the OnCovid Inflammatory Score (2021) (0)
- Faculty Opinions recommendation of Contrasting Roles of the PD-1 Signaling Pathway in Dendritic Cell-Mediated Induction and Regulation of HIV-1-Specific Effector T Cell Functions. (2019) (0)
- The influence of HAART on HIV-associated primary cerebral lymphoma: Declining incidence and improving survival. (2006) (0)
- P35 Is there an association between choice of thymidine analogue and lipid abnormalities in HIV-1-infected patients? (2000) (0)
- Faculty Opinions recommendation of Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies. (2019) (0)
- From the European Medicines Agency to Project Orbis: new activities and challenges to facilitate UK oncology drug approval following Brexit. (2023) (0)
- Excellent Immune Recovery Following the Intensive Chemotherapy CODOX-M/IVAC, An Effective Therapy for HIV-Associated Burkitt’s Lymphoma (BL) (2008) (0)
- COMPARISON OF OUTCOMES BETWEEN PATIENTS WITH MYC REARRANGED DLBCL AND DOUBLE/ TRIPLE HIT HIGH‐GRADE B CELL LYMPHOMA: A PAN‐LONDON RETROSPECTIVE REVIEW (2019) (0)
- Faculty Opinions recommendation of High-dose therapy and autologous peripheral blood stem cell transplantation as salvage treatment for AIDS-related lymphoma: long-term results of the Italian Cooperative Group on AIDS and Tumors (GICAT) study with analysis of prognostic factors. (2009) (0)
- Faculty Opinions recommendation of Phase II Trial of Lenalidomide in HIV-Infected Patients with Previously Treated Kaposi's Sarcoma: Results of the ANRS 154 Lenakap Trial. (2019) (0)
- Do the mutations M046I and I047A confer resistance to kaletra? (2006) (0)
- The Burkitt Lymphoma International Prognostic Index (BL-IPI) (2020) (0)
- Faculty Opinions recommendation of Patterns of distribution of childhood cancer in Africa. (2019) (0)
- HIV-associated bladder cancer: diagnosis and management (2009) (0)
- New concepts in anti-HIV therapies (2006) (0)
- A43Gemcitabine as single agent second line treatment in patients with advanced wild-type EGFR, negative ALK non-small cell lung cancer: a retrospective study (2016) (0)
- Acute diagnostic oncology clinic: tackling emergency presentations of cancer (2016) (0)
- Faculty Opinions recommendation of Kaposi sarcoma: no longer an AIDS-defining illness? A retrospective study of Kaposi sarcoma cases with CD4 counts above 300/mm³ at presentation. (2019) (0)
- Methylation reversal in high-grade B lymphoma cell lines and novel epigenetic changes conserved between immunocompetent and HIV-positive hosts. (2016) (0)
- FaFEC: a novel regimen for advanced ovarian cancer. (1997) (0)
- 504P SARS-CoV-2 Omicron (B.1.1.529) variant infection leads to high morbidity and mortality in unvaccinated patients with cancer (2022) (0)
- Local excision and treatment of early node-negative anal squamous cell carcinomas in a highly HIV prevalent population (2021) (0)
- 31 Histolopathological trends in HIV-associated lung cancer (2011) (0)
- Conserved epigenetic changes in sporadic and HIV-associated high-grade B-cell lymphomas (2007) (0)
- TOPICAL VITAMIN D ANALOGUES IN ADVANCED BREAST CANCER (1991) (0)
- Faculty Opinions recommendation of Decreased levels of the serum inflammatory biomarkers, sGP130, IL-6, sCRP and BAFF, are associated with increased likelihood of AIDS related Kaposi’s sarcoma in men who have sex with men. (2019) (0)
- Faculty Opinions recommendation of Transient HIV-specific T cells increase and inflammation in an HIV-infected patient treated with nivolumab. (2019) (0)
- 109: Characteristics of HIV-associated lung cancer (2017) (0)
- AIDS-related cancers, Part I: Kaposi's sarcoma and cervical cancer (2005) (0)
- Faculty Opinions recommendation of Comparable survival between HIV+ and HIV- non-Hodgkin and Hodgkin lymphoma patients undergoing autologous peripheral blood stem cell transplantation. (2009) (0)
- Faculty Opinions recommendation of PD-1 blockade with nivolumab in endemic Kaposi sarcoma. (2019) (0)
- Acute diagnostic oncology clinic: A unique primary care-oncology service (2019) (0)
- Prognostic Factors in Patients with HIV-Associated Hodgkin Lymphoma: An Analysis of 199 Cases (2012) (0)
- Referee acknowledgement for 2017 (2018) (0)
- Ezetimibe as lipid-lowering therapy for patients receiving HAART (2008) (0)
- Faculty Opinions recommendation of Randomized comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma. International Pegylated Liposomal Doxorubicin Study Group. (2019) (0)
- multicentric Castleman disease Rituximab as retreatment for rituximab pretreated HIV-associated (2012) (0)
- 437 Safety and efficacy of immune checkpoint inhibitors (ICI) in patients living with HIV (PLWH) and metastatic non-small cell lung cancer (NSCLC): a matched cohort study from the international CATCH-IT consortium (2022) (0)
- H06Advanced non-small cell lung cancer (NSCLC): the prognostic role of systemic Immune-Inflammation Index (SII) (2015) (0)
- Contents Vol. 93, 2017 (2017) (0)
- A comparison of patients' attitudes to antiretroviral toxicities between the UK and Uganda. (2011) (0)
- Blue Planet Prizes (1993) (0)
- PROX1 is a transcriptional regulator of MMP14 (2018) (0)
- AIDS-related cancers, Part II: Systemic and cerebral lymphomas (2006) (0)
- THE ADDITION OF RITUXIMAB TO CODOX-M/IVAC CHEMOTHERAPY IN THE TREATMENT OF BURKITT LYMPHOMA IS SAFE AND IS ASSOCIATED WITH INCREASED EFFICACY IN THE HIV POSITIVE POPULATION (2014) (0)
- Faculty Opinions recommendation of HIV-associated malignancies in sub-Saharan Africa: progress, challenges, and opportunities. (2019) (0)
- infected individuals - Conservation of unique cell-surface CD antigen mosaics in HIV-1 (2013) (0)
- 3092 Systemic immune-inflammation index (SII) in patients with advanced non-small cell lung cancer (nsclc) (2015) (0)
- ALL , AML , MDS & bone marrow failure BSH 2021-PO-001 NGS cannot replace standard fragment analysis for the detection of FLT 3-ITD (2021) (0)
- Review Anal intraepithelial neoplasia in HIV positive people (2001) (0)
- Faculty Opinions recommendation of Antineoplastic activity of lentiviral vectors expressing interferon-alpha in a preclinical model of primary effusion lymphoma. (2009) (0)
- International Congress of Drug Therapy in HIV Infection 2‐6 November 2014, Glasgow, UK (2014) (0)
- Cancer Risk and Sedative Hypnotics (2018) (0)
- Faculty Opinions recommendation of Kaposi's sarcoma: a 10-year experience with 248 patients at a single tertiary care hospital in Tanzania. (2019) (0)
- HBV and lymphoma: HIV matters (2011) (0)
- Early determination of treatment sensitivity in HIV-related Hodgkin lymphoma by FDG-PET/CT after two cycles of ABVD chemotherapy: A European Cooperative Study Group on AIDS and Tumors (GECAT) study. (2017) (0)
- HIV infection adversely influences the natural history of untreated hepatocellular carcinoma (HCC) (2018) (0)
- The systemic inflammatory response is a prognostic marker in human immunodeficiency virus-infected patients with hepatocellular carcinoma (2017) (0)
- Faculty Opinions recommendation of Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial. (2019) (0)
- The increasing incidence of HIV-associated multicentric Castlemans disease (2008) (0)
- Faculty Opinions recommendation of PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma. (2019) (0)
- Multicenter S tudy o f H uman I mmunodeficiency Virus-Related G erm C ell T umors (2003) (0)
- Faculty Opinions recommendation of Drastic decrease of the HIV reservoir in a patient treated with nivolumab for lung cancer. (2019) (0)
- Doctor–patient communication (2018) (0)
- Recovery of cellular immunity following chemotherapy for AIDS related non Hodgkin's lymphoma (2008) (0)
- NKG2C (cid:1) NK Cells Are Enriched in AIDS Patients with Advanced-Stage Kaposi’s Sarcoma (cid:1) (2006) (0)
- H11Hyponatremia normalization as an independent prognostic factor in patients with advanced non-small cell lung cancer treated with first-line therapy (2015) (0)
- HIV-associated malignancies (2015) (0)
- 1203 Target prices for mass production of Tyrosine Kinase Inhibitors (TKIs) for global cancer treatment access (2015) (0)
- Prognostic significance of loss of chromosome 10 in high grade gliomas. (1999) (0)
- Faculty of 1000 evaluation for Use of antineoplastic agents in patients with cancer who have HIV/AIDS. (2011) (0)
- 012 AIDS‐related lymphoma in the era of HAART (2000) (0)
- Lecture Notes: Oncology Ed. 3 (2015) (0)
- Outcomes of men with HIV and germ cell cancer: Results from an international collaborative study (2021) (0)
- Anal squamous cell carcinoma in a high HIV prevalence population. (2021) (0)
- Anti-retroviral treatment regimens and immune parameters in the prevention of systemic HIV-related non-Hodgkin's lymphoma. (2004) (0)
- 110: Drug interactions with systemic anti-cancer therapy in lung cancer patients (2017) (0)
- JC – a forgotten foe or a foe to be forgotten? (2013) (0)
- Reply to S.E. Krown et al. (2014) (0)
- SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry (2023) (0)
- Abstract 701: The acute phase response identifies cancer patients with adverse outcomes from SARS-CoV-2 infection as quantified by the OnCovid Inflammatory Score (2021) (0)
- Non cutaneous AIDS-associated Kaposi's sarcoma. (2006) (0)
- Comparison of Outcomes Between Patients with MYC Rearranged DLBCL and Double/Triple Hit High-Grade B-Cell Lymphoma: A Pan-London Retrospective Review (2019) (0)
- New therapies for hepatitis infection (2006) (0)
- Current management of AIDS related non Hodgkin’s lymphoma (2008) (0)
- Clinical effectiveness of SARS-CoV-2 vaccines and booster doses in patients with cancer: An analysis from the European OnCovid registry. (2022) (0)
- AIDS-related cancers (2009) (0)
- Faculty Opinions recommendation of Pomalidomide for symptomatic kaposi's sarcoma in people with and without HIV infection: A phase I/II study. (2019) (0)
- Does highly active antiretroviral therapy (HAART) affect the incidence or outcome of invasive anal cancer (2004) (0)
- 114TiP Preliminary assessment of safety and tolerability of dostarlimab in combination antiretroviral therapy (cART)-refractory HIV-associated Kaposi sarcoma (StarKap) (2023) (0)
- ArticlePresenting features and early mortality from SARS-CoV- (2020) (0)
- Faculty Opinions recommendation of Successful Treatment of HIV-Associated Kaposi Sarcoma with Immune Checkpoint Blockade. (2019) (0)
- HIV Infection and Esophageal Cancer—Reply (2010) (0)
- Complementary and alternative medicine in cerebral palsy (2009) (0)
- HIV-1-infected individuals Conservation of unique cell-surface CD antigen mosaics in (2010) (0)
- Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: a joint analysis of OnCovid and ESMO-CoCARE registries (2022) (0)
- Editorial: a step forward in refining prognostication for patients with HIV‐associated hepatocellular carcinoma—Authors’ reply (2018) (0)
- Liver transplantation for human immunodeficiency virus-Infected patients with hepatocellular carcinoma (2017) (0)
- Integrated phenotyping of the anti-cancer immune response in HIV-associated hepatocellular carcinoma (2020) (0)
- Host immunogenetics and control of human herpesvims-8 infection. Commentary (2006) (0)
- P7. Effects of calcipotriol (MC903) on breast cancer cells in vitro and in vivo (1992) (0)
- Managing risk on clinical placements (2011) (0)
- 3434 A UK national phase I/II clinical trial of a MEK1/2 inhibitor combined with highly active anti-retroviral therapy for HIV-associated Kaposi's sarcoma (2015) (0)
- AIDS-Related Malignancy (2020) (0)
- Taxonomic reclassification of Kaposi Sarcoma identifies disease entities with distinct immunopathogenesis (2023) (0)
- Comprar Lecture Notes: Oncology | Peter Mills | 9781405124027 | Wiley (2009) (0)
- Outcome of men with HIV-associated germ cell cancer: Results from an international collaborative study. (2020) (0)
- Lung cancer in people living with HIV. (2022) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Mark Bower?
Mark Bower is affiliated with the following schools:
